INMB
CFO, Board Member
Board Member
Inmune Bio, Inc. (INMB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Cory Ellspermann is recorded as CFO and Board Member at Inmune Bio, Inc. (INMB). Inmune Bio, Inc. reported in an 8-K filed November 28, 2025 that Cory Ellspermann was appointed Chief Financial Officer, effective November 1, 2025. The proxy statement of Inmune Bio, Inc. reports total compensation of $619,227 for Cory Ellspermann in fiscal 2025, including a base salary of $190,938. Cory Ellspermann has spoken on 2 earnings calls across 1 company, most recently for Inmune Bio, Inc. on March 31, 2026.
“INmune Bio Inc. (the "Company") is pleased to offer you continued at-will employment in the position of Chief Financial Officer on the terms and conditions set forth in this letter agreement (the "Agreement").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
INMB
CFO, Board Member
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inmune Bio, Inc. (INMB) | CFO | $190,938 | $619,227 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.